DE1957246A1 - Process for the preparation of 3beta-hydroxy-5beta-cardenolides - Google Patents
Process for the preparation of 3beta-hydroxy-5beta-cardenolidesInfo
- Publication number
- DE1957246A1 DE1957246A1 DE19691957246 DE1957246A DE1957246A1 DE 1957246 A1 DE1957246 A1 DE 1957246A1 DE 19691957246 DE19691957246 DE 19691957246 DE 1957246 A DE1957246 A DE 1957246A DE 1957246 A1 DE1957246 A1 DE 1957246A1
- Authority
- DE
- Germany
- Prior art keywords
- hydroxy
- cardenolides
- preparation
- iridium
- 5beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title claims description 3
- SNNJOYYRZHOKFM-QBFOWDOUSA-N 3-[(3s,5r,8r,9s,10s,13s,14r,17s)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2h-furan-5-one Chemical class C1([C@H]2CC[C@@H]3[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)=CC(=O)OC1 SNNJOYYRZHOKFM-QBFOWDOUSA-N 0.000 title 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 229910021638 Iridium(III) chloride Inorganic materials 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 150000003863 ammonium salts Chemical class 0.000 claims description 2
- DANYXEHCMQHDNX-UHFFFAOYSA-K trichloroiridium Chemical compound Cl[Ir](Cl)Cl DANYXEHCMQHDNX-UHFFFAOYSA-K 0.000 claims description 2
- MOHYGSBMXIJZBJ-UHFFFAOYSA-N [Ir+4] Chemical compound [Ir+4] MOHYGSBMXIJZBJ-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- FFQCZYROKVPTGV-UHFFFAOYSA-N Cl.[Ir+4] Chemical compound Cl.[Ir+4] FFQCZYROKVPTGV-UHFFFAOYSA-N 0.000 description 4
- XZTUSOXSLKTKJQ-UHFFFAOYSA-N Uzarigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C1(O)CCC2C1=CC(=O)OC1 XZTUSOXSLKTKJQ-UHFFFAOYSA-N 0.000 description 4
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- XZTUSOXSLKTKJQ-CESUGQOBSA-N digitoxigenin Chemical compound C1([C@H]2CC[C@]3(O)[C@H]4[C@@H]([C@]5(CC[C@H](O)C[C@H]5CC4)C)CC[C@@]32C)=CC(=O)OC1 XZTUSOXSLKTKJQ-CESUGQOBSA-N 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- -1 saturated keto steroids Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 2
- HXXNSZGESRDYFE-JIUSCHCVSA-N 1-[(8r,9s,10s,13s,14s,17s)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC21 HXXNSZGESRDYFE-JIUSCHCVSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- JIUWTCXNUNHEGP-FEPOTVBBSA-N 3-[(5S,8R,9S,10S,13S,14R,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one Chemical compound C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CCCC[C@]34C)[C@H]1CC[C@@H]2C=1COC(=O)C=1 JIUWTCXNUNHEGP-FEPOTVBBSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- TYYDXNISHGVDGA-UHFFFAOYSA-N Corotoxigenin Natural products CC12CCC3C(CCC4CC(O)CCC34C=O)C1CCC2C5=CC(=O)OC5 TYYDXNISHGVDGA-UHFFFAOYSA-N 0.000 description 1
- QAQPABLODWMGOS-JVWMIROESA-N O=C1C[C@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@@H]3CC[C@@H]4C=3COC(=O)C=3)[C@]2(CC1)C Chemical class O=C1C[C@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@@H]3CC[C@@H]4C=3COC(=O)C=3)[C@]2(CC1)C QAQPABLODWMGOS-JVWMIROESA-N 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JIUWTCXNUNHEGP-GJHPUSIBSA-N cardenolide Chemical compound C1([C@H]2CC[C@@H]3[C@H]4[C@@H]([C@]5(CCCCC5CC4)C)CC[C@@]32C)=CC(=O)OC1 JIUWTCXNUNHEGP-GJHPUSIBSA-N 0.000 description 1
- 150000001738 cardenolides Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
FARBV/ERKE HOECHST AG., vormals Meister Lucius & Brüning Aktenzeichen: Pw 6256FARBV / ERKE HOECHST AG., Formerly Master Lucius & Brüning File number: Pw 6256
Datum: 13. Nov. I969Date: Nov. 13, 1969
"Verfahren ζ ur.. He r st e 1.1 u η g von .3 ^---Hy d r oxy - 5.ß -c a rcle nc 1 ide 11""Procedure ζ ur .. He r st e 1.1 u η g of .3 ^ --- Hy dr oxy - 5.ß -ca rcle nc 1 ide 11"
Aus dem belgischen Patent No. 707-326 ist bereits bekannt, ;5ß-Hydroxy-5ß-cardenolide herzustellen, wobei ]5-Keto-5ßcarderiolide zunächst mit komplexen Metallhydriden zu den entsprechenden 3^-Hydroxyverbindungen reduziert und diese anschließend durch Waiden1sehe Umkehr in die 3ß-Cardenolide umgeviandelt v/erden.From the Belgian patent no. 707-326 is already known to produce; 5ß-hydroxy-5ß-cardenolide, where] 5-keto-5ßcarderiolide is first reduced with complex metal hydrides to the corresponding 3 ^ -hydroxy compounds and these are then converted into 3ß-cardenolides by Waiden 1 see reversal v / earth.
Es wurde bereits vorgeschlagen, 3ß~Hydroxy~5ß-cardenolide dadurch herzustellen, daß man ]5-Keto-5ß-cardenolide mit Alurninium-Alkoholat nach Meerwein-Ponndorf reduziert unddie in etwa gleicher Menge gleichzeitig entstandenen 3°\ -Hydroxy-cardenolide abtrennt, sie zu 3-Keto-5ß-cardenoliden wieder dehydriert, wonach sie erneut der Meerwein-Ponndorf-Reduktion unterworfen werden können.It has already been suggested that 3β ~ hydroxy ~ 5β-cardenolide by producing] 5-keto-5ß-cardenolide with Aluminum alcoholate reduced by Meerwein-Ponndorf and the separates 3 ° \ -hydroxy-cardenolides formed at the same time in approximately the same amount, converting them to 3-keto-5β-cardenolides dehydrated again, after which she again did the Meerwein-Ponndorf reduction can be subjected.
Gegenstand der vorliegenden Erfindung ist ein einfaches und glattverlaufendes Verfahren zur Herstellung von 3ß-Hydroxy-5ß-cardenoliden der 14-Dehydro- oder I4ß-reihe, daß dadurch gekennzeichnet ist, daß man entsprechende 3-Keto~5ß~cardenolide mit Iridium(IV)-chlorwasserstoffsaure, deren Alkali- bzw. Arnrnoniurn-Salzen oder Iridium( III)-Chlorid in Gegenwart von Trialkylphosphit und niederen Alkoholen behandolt.The present invention relates to a simple and smooth process for the preparation of 3ß-hydroxy-5ß-cardenolides the 14-dehydro- or I4ß-series that thereby is characterized in that one corresponding 3-keto ~ 5 ~ cardenolide with iridium (IV) hydrochloric acid, the alkali or Ammonium salts or iridium (III) chloride in the presence of Trialkyl phosphite and lower alcohols.
Das Verfahren verläuft beiapielsv/eise nach folgendem Forme lnoherna:In the case of apiels, the procedure is as follows Form lnoherna:
10982 1/2 19910982 1/2 199
BAP OBiGiNALBAP OBiGiNAL
Fv; 6256Fv; 6256
IrJ Ir J
Als Ausgangsstoffe koriirnen. beispielsweise infrage:Corn as raw materials. for example in question:
oder
;ir--Koto-liiß"hydroz/-5ß-card--?.0(22)-eriolidor
-eriolid ?. 0 (22) - ir - Koto-l i eat "hydroz / -5ß-card;
10 9 8 2 1/219910 9 8 2 1/2199
BAD ORIGINALBATH ORIGINAL
• Fw 625Ö-• Fw 625Ö-
Die Reduktion wird in üblicher V<reise .durchgeführt, indem man das lösliche Iridium(IIl) - bzv/. (IV)-sals, von dem man vorzugsweise katalytische Mengen verwendet, in niedermolekularen Alkoholen in Gegenwart von Trialkylphosphit längere Zeit, etwa 1 bis 5 Tage, vorzugsweise 50 bis 1-50 Stunden, unter Rückfluß zum Sieden erhitzt. Als niedere Alkohole verwendet man vorteilhaft Propanol-2, welches vorteilhaft bis zu 10 % Wasser enthält. Als Trialkylphosphit wird vorteilhaft Trimethylphosphit, mindestens in stöchiometrischen ilengen, verwendet. Man kann mit oder ohne Zusatz von wenig Mineralsäure arbeiten. Bei der Verwendung von Iridturn( III)-Chlorid in der 14-Dehydroreihe ist die Zugabe von etwas konzentrierter Salzsäure von Vorteil.The reduction is in conventional V <r else .durchgeführt by the soluble iridium (IIl) - BZV /. (IV) -sals, of which catalytic amounts are preferably used, in low molecular weight alcohols in the presence of trialkyl phosphite for a long time, about 1 to 5 days, preferably 50 to 1-50 hours, heated to boiling under reflux. The lower alcohols used are advantageously 2-propanol, which advantageously contains up to 10 % water. The trialkyl phosphite used is advantageously trimethyl phosphite, at least in stoichiometric amounts. You can work with or without the addition of a little mineral acid. When using Iridturn (III) chloride in the 14-dehydro series, the addition of a little concentrated hydrochloric acid is advantageous.
Das zu reduzierende j5-Keto-5ß~cardenolid kann sofort oder erst nach einigen Stunden (bis zu 15 Stunden) zum Reduktionsgemisch gegeben werden. Nach Ende der Reaktion wird das Reaktionsgemisch aus der wässrigen Lösung, z.B. durch Absaugen oder Extrahieren mit organischen Lösungsmitteln, entfernt.The j5-keto-5ß-cardenolide to be reduced can either immediately or first after a few hours (up to 15 hours) to the reduction mixture are given. After the end of the reaction, the reaction mixture is removed from the aqueous solution, e.g. by suction or Extracting with organic solvents, removed.
Der Vorteil des erfindungsgemäßen Verfahrens gegenüber dem aus dem belgischen Patent No. 707 326 bekannten Verfahren beruht einmal in der. Einsparung von mehreren Reaktionsstufen. Bei dem bekannten Verfahren wird zunächst reduziert, anschließend mit p-Toluolsulfochlorid verestert und dieses schließlich mit Kaliumformiat (Walden-Umkehr) umgelagert. Die Gesamtausbeute beträgt ca. 4o %. Dagegen ist bei den erfindungsgemäGen Verfahren die Urnsetzung, mit p-Toluolsulfochlorid und anschließende Waiden'sehe Umkehr nicht erforderlich, außerdem werden Ausbeuten von über 90 % erhalten.The advantage of the method according to the invention over that from Belgian patent no. 707 326 known method is based once in the. Saving of several reaction stages. In the known process, it is first reduced, then esterified with p-toluenesulphochloride and this finally rearranged with potassium formate (Walden inversion). The total yield is about 40 %. In contrast, in the process according to the invention, the reaction with p-toluenesulphonyl chloride and subsequent Waiden's-see reversal is not necessary, and yields of over 90 % are obtained.
Die Reduktion von J-Keto-androstan- und 3-Ke to-pregnan-Derivaten zu den entsprechenden axialen jJ3 -Hy ar oxy verb indungen irjt in J.Chew.Soc. (C) (19^9)» Seiten Io5."5 - I659, beschrieben.The reduction of J-keto-androstane and 3-Ke to-pregnane derivatives to the corresponding axial jJ3 -Hy ar oxy connections irjt in J.Chew.Soc. (C) (19 ^ 9) "Pages Io5." 5-1659.
+ ) mit Iridium(IV)-chlorwasserstoffsäure + ) with iridium (IV) hydrochloric acid
/4 109821/2199 / 4 109821/2199
Fw 6256Fw 6256
Die Anwendung des gleichen Reduktionsmittels auf Steroide, die den empfindlichen cK,ß-ungesättigten Lactonring enthalten, mußte im Hinblick auf die letztgenannte Literaturstelle durchaus zweifelhaft erscheinen. In der bekannten Reaktion war lediglich die Reduktion von gesättigten Keto-Steroiden beschrieben worden, es mußte mit einer - uner-The use of the same reducing agent on steroids containing the sensitive cK, ß-unsaturated lactone ring must appear doubtful in view of the last-mentioned reference. In the known reaction, only the reduction of saturated keto steroids had been described, it had to be done with an - un-
ί wünschten - Einwirkung des Reagenzes auf Doppelbindungen,ί desired - action of the reagent on double bonds,
z.B. in 14,15-Stellung von Steroiden, gerechnet werden. Es hätte z.B. eine teilweise Umwandlung der thermodynamisch labilen Cardenolide der 1'4-Dehydro- bzw. I4ß-reihe in die fe stabileren 8(14) bzw. 8(9)-Dehydrocardenolide bzw. -Isocardenolide stattfinden können. Außerdem ist aus der genannten Literaturstelle bekannt, daß z.B. Pregnan-20ß-öl oder 21-Hydroxy-pregnan-20-on von dem Reagenz in z.T. nicht übersehbarer Art und Weise angegriffen werden. Die Pregnan-20-on-seitenkette wiederum erleidet eine Epimerisierung in IT-Stellung.e.g. in the 14,15 position of steroids. For example, there would have been a partial conversion of the thermodynamically labile cardenolides of the 1'4-dehydro- or I4ß-series into the fe more stable 8 (14) or 8 (9) -Dehydrocardenolide or -Isocardenolide can take place. In addition, it is known from the cited literature that, for example, Pregnan-20β-oil or 21-hydroxy-pregnan-20-one can be attacked by the reagent in a way that cannot be overlooked. The Pregnan-20-on-side chain in turn suffers epimerization in IT position.
Mittels des erfindungsgemäßen Verfahrens ist es nunmehr überraschende rweise möglich, in glatter Reaktion mit sehr guten Ausbeuten zu der wichtigen 3ß-reihe der. Digi-toxigeninsteroide zu gelangen; man erhält entweder in der 14ß-Hydroxy-. reihe direkt das hochv/irksame Herzmittel Digitoxigenin oder ' gelangt zu dessen Vorstufe, dem 14,20(22)-dienolid, Vielehe nach bekannten Verfahren in Digitoxigenin überführt werden kann.By means of the method according to the invention it is now surprising R occasionally possible, in a smooth reaction with very good yields to the important 3β series of. Digi-toxigenin steroids to get; you get either in the 14ß-hydroxy. series directly the highly effective cardiac remedy digitoxigenin or 'arrives at its precursor, 14.20 (22) -dienolide, polygamy be converted into digitoxigenin by known methods can.
/5 109821/2199/ 5 109821/2199
B1W 6256'· - 5 -B 1 W 6256 '- 5 -
3ß-Hydroxy-5ß-carda-l4,2o(22)-dienolid 3β- hydroxy-5β-carda-14,2o (2 2) -di enolide
Zu einer gerührten Suspension von 10 g 3-Keto-5ß-carda-14,20(22)-dienolid in 250 ecm 90 tigern Propanol-2 werden 20 ecm Trimethylphosphit und 500 mg Iridium(lV)-chlorwasserstoff säure eingetragen. Dann wird das Reaktionsgemisch 62 Stunden lang unter Rühren und unter Rückflußkühlung zum Sieden erhitzt. Nach 49 Stunden ist.alles Ausgangsmaterial in Lösung gegangen. Nach Ablauf der Gesamtreaktionszeit v/ird die klare, nahezu farblose Lösung in 1 Liter Wasser eingerührt. Das ausgefallene Reaktionsprodukt wird abgesaugt, mit V/asser gewaschen und in Methylenchlorid aufgenommen. Nach dem Waschen mit Wasser und Trocknen über Natriumsulfat wird im Vakuum zur Trockne eingeengt. Nach dem Umkristallisieren aus Methylenchlorid/Methanol werden 9.15 g 3ß-Hydroxy-5ß-carda-14,20(22)-dienolid vom Schmelzpunkt I95 bis I990 C (korr.)20 ecm of trimethyl phosphite and 500 mg of iridium (IV) hydrochloric acid are added to a stirred suspension of 10 g of 3-keto-5ß-carda-14, 20 (22) dienolide in 250 ecm of 90 tiger propanol-2. The reaction mixture is then heated to boiling for 62 hours with stirring and under reflux cooling. After 49 hours, all the starting material has gone into solution. After the total reaction time has elapsed, the clear, almost colorless solution is stirred into 1 liter of water. The precipitated reaction product is filtered off with suction, washed with water and taken up in methylene chloride. After washing with water and drying over sodium sulfate, it is concentrated to dryness in vacuo. After recrystallization from methylene chloride / methanol 9.15 g of 3.beta.-hydroxy-5ß-carda-14,20 (22) -dienolid a melting point of I95 to I99 0 C (corr.)
[cX]D= -28° J[<*]j65 = -160° (Chloroform 0,5 %) erhalten.[cX] D = -28 ° J [<*] j 65 = -160 ° (chloroform 0.5 %) .
Aus den Mutterlaugen können ca. 4θΟ mg (== 4 %) 5 ^-Hydroxy-5ß-carda-l4,20(22)-dienolid vom Schmelzpunkt I960 C mittels Chromatographie erhalten'werden.Can erhalten'werden ^ -hydroxy-5ß-carda-l4,20 (22) -dienolid a melting point of I96 0 C by means of chromatography about 4θΟ mg (== 4%) 5 from the mother liquors.
, l4ß-Dihydroxy-5ß-card-20( 2?.) -enolid (Dlgltoxisenin), 14ß-Dihydroxy-5ß-card-20 ( 2 ?.) -enolide (Dlgltoxisenin)
Zu einer Lösung von 5.0 g j5-Keto-l4n-lvdr-oxy-5G-card-20(22)'-cnolLd in 250-ml Propanol-2 (90 $iß) werden 10 ml Trircethyl-To a solution of 5.0 g of j5-keto-l4n-lvdr-oxy-5G-card-20 (22) '- cnolLd in 250 ml propanol-2 (90%) 10 ml trircethyl-
/6 109821 /2199/ 6 109821/2199
Fw 6256 - 6 -Fw 6256 - 6 -
phosphit und 250 mg Iridium(IV)-chlorwasserstoffsäure eingetragen. Anschließend wird das Reaktionsgemisch l4o Stunden lang unter Rückfluß zum Sieden erhitzt. Dann wird rasch abgekühlt und in 4θΌ ml V/asser eingerührt. Anschließend wird mit Chloroform extrahiert. Der Extrakt wird mit V/asser neutral gewaschen, über Natriumsulfat getrocknet und im Vakuum zur Trockne eingeengt. Nach dem Umkristallisieren aus Aceton/Petroläther werden 4,25 S Digitoxigenin vom Schmelzpunkt 240 - 2420C, [o(] ß = 18.1° C (in CHCl5) erhalten. phosphite and 250 mg of iridium (IV) hydrochloric acid. The reaction mixture is then refluxed for 140 hours. It is then cooled rapidly and stirred into 4θΌ ml v / water. It is then extracted with chloroform. The extract is washed neutral with water / water, dried over sodium sulfate and concentrated to dryness in vacuo. After recrystallization from acetone / petroleum ether 4.25 S digitoxigenin of melting point 240-242 0 C obtained [o (] B = 18.1 ° C (in CHCl 5).
109821/2199109821/2199
Claims (1)
der 3A-Dehydro- oder I4ß-reihe, dadurch gekennzeichnet,
daß man entsprechende j5-Ke.to-5ß-cardenolide mit Iridium(lV)· chlorwasserstoffsäure, deren Alkali- bzw. Ammonium-Salzen
oder Iridium(III)-Chlorid in Gegenwart von Trialkylphosphit und niederen Alkoholen behandelt.Process for the preparation of 5 [beta] -hydroxy-5 [beta] -cardenolides
the 3A-Dehydro- or I4ß-series, characterized by
that one corresponding j5-Ke.to-5ß-cardenolide with iridium (IV) · hydrochloric acid, its alkali or ammonium salts
or treated iridium (III) chloride in the presence of trialkyl phosphite and lower alcohols.
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE758859D BE758859A (en) | 1969-11-14 | PROCESS FOR PREPARING CARDENOLIDES | |
DE19691957246 DE1957246A1 (en) | 1969-11-14 | 1969-11-14 | Process for the preparation of 3beta-hydroxy-5beta-cardenolides |
BR215367/69A BR6915367D0 (en) | 1969-11-14 | 1969-12-19 | PROCESS FOR THE PREPARATION OF 3 BETA-HIDROXI-5 BETA-CARDENOLIDEOS |
NL7016368A NL7016368A (en) | 1969-11-14 | 1970-11-09 | |
CH1668070A CH529122A (en) | 1969-11-14 | 1970-11-11 | Process for the preparation of 3B-hydroxy-5B-cardenolides |
DK575770AA DK128351B (en) | 1969-11-14 | 1970-11-12 | Process for the preparation of 3β-hydroxy-5β-cardenolides from the 14-dehydro- or 14β-hydroxy series. |
GB5426170A GB1327438A (en) | 1969-11-14 | 1970-11-13 | Process for the manufacture of 3beta-hydroxy-5beta-card- 20-22- enolides |
AT1025570A AT306935B (en) | 1969-11-14 | 1970-11-13 | Process for the preparation of 3β-hydroxy-14-dehydro (or 14β-hydroxy) -5β-cardenolides |
JP45100104A JPS5023027B1 (en) | 1969-11-14 | 1970-11-13 | |
FR7040701A FR2069360A5 (en) | 1969-11-14 | 1970-11-13 | |
SE7015337A SE376619B (en) | 1969-11-14 | 1970-11-13 | |
CA098045A CA922692A (en) | 1969-11-14 | 1970-11-13 | PROCESS FOR THE MANUFACTURE OF 3 .beta.-HYDROXY-5 .beta.-CARDENOLIDES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691957246 DE1957246A1 (en) | 1969-11-14 | 1969-11-14 | Process for the preparation of 3beta-hydroxy-5beta-cardenolides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1957246A1 true DE1957246A1 (en) | 1971-05-19 |
Family
ID=5751058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19691957246 Pending DE1957246A1 (en) | 1969-11-14 | 1969-11-14 | Process for the preparation of 3beta-hydroxy-5beta-cardenolides |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS5023027B1 (en) |
AT (1) | AT306935B (en) |
BE (1) | BE758859A (en) |
BR (1) | BR6915367D0 (en) |
CA (1) | CA922692A (en) |
CH (1) | CH529122A (en) |
DE (1) | DE1957246A1 (en) |
DK (1) | DK128351B (en) |
FR (1) | FR2069360A5 (en) |
GB (1) | GB1327438A (en) |
NL (1) | NL7016368A (en) |
SE (1) | SE376619B (en) |
-
0
- BE BE758859D patent/BE758859A/en unknown
-
1969
- 1969-11-14 DE DE19691957246 patent/DE1957246A1/en active Pending
- 1969-12-19 BR BR215367/69A patent/BR6915367D0/en unknown
-
1970
- 1970-11-09 NL NL7016368A patent/NL7016368A/xx unknown
- 1970-11-11 CH CH1668070A patent/CH529122A/en not_active IP Right Cessation
- 1970-11-12 DK DK575770AA patent/DK128351B/en unknown
- 1970-11-13 FR FR7040701A patent/FR2069360A5/fr not_active Expired
- 1970-11-13 GB GB5426170A patent/GB1327438A/en not_active Expired
- 1970-11-13 AT AT1025570A patent/AT306935B/en not_active IP Right Cessation
- 1970-11-13 CA CA098045A patent/CA922692A/en not_active Expired
- 1970-11-13 SE SE7015337A patent/SE376619B/xx unknown
- 1970-11-13 JP JP45100104A patent/JPS5023027B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2069360A5 (en) | 1971-09-03 |
CA922692A (en) | 1973-03-13 |
AT306935B (en) | 1973-04-25 |
CH529122A (en) | 1972-10-15 |
SE376619B (en) | 1975-06-02 |
JPS5023027B1 (en) | 1975-08-05 |
GB1327438A (en) | 1973-08-22 |
DK128351B (en) | 1974-04-16 |
NL7016368A (en) | 1971-05-18 |
BE758859A (en) | 1971-05-12 |
BR6915367D0 (en) | 1973-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2404946C3 (en) | Process for the preparation of 7alpha-acylthio-steroid spirolactones | |
DE1957246A1 (en) | Process for the preparation of 3beta-hydroxy-5beta-cardenolides | |
DE1568308B2 (en) | PROCESS FOR MANUFACTURING DELTA HIGH 4,9,11-TRIENES OF THE 19-NOR- ANDROSTAN SERIES, 17-OXYGENATED 3-OXO- 7 ALPHA-METHYL-DELTA HIGH 4,9,11-19 NOR- ANDROSTATRIENE AND PHARMACEUTICALS CONTAINING THESE PRODUCTS 3-OXO-7 ALPHA -METHYL-DELTA UP 5 (10), 9 (11) -19-NOR- ANDROSTADIENE | |
DE1518469A1 (en) | Process for the preparation of B-homoesterene compounds substituted in 3,7,17 positions | |
DE2137546C3 (en) | Process for the production of 17alpha Athynyl, Methyl and Vinyl 17beta Acetyloxysteroiden of the androstane or Ostran series | |
AT323343B (en) | METHOD OF MANUFACTURING NEW STEROIDS | |
DE1807585C3 (en) | 14,15beta-epoxy cardenolides, processes for their preparation and compositions containing them | |
DE962791C (en) | Process for the preparation of 21-bromoallopregnane derivatives | |
DE959189C (en) | Process for the preparation of 17ª ‰ -acyloxy-20-keto-allopregnans and -pregnenes | |
DE1921778C (en) | Process for the preparation of 2-position substituted steroid oxa beans | |
DE1793703C3 (en) | Process for the preparation of 3,20-dioxo-16 alpha, 17 alpha-dihydroxy-19-norpregna-4-en | |
DE871301C (en) | Process for the preparation of oxo compounds of the pregnane series | |
AT274248B (en) | Process for the preparation of new derivatives of bufadienolide glycosides | |
DE2030685B2 (en) | 17-ureido compounds of the androstane series as inhibitors of the biosynthesis of androgens and processes for their production | |
DE2319873A1 (en) | 16-O-ALKYL DERIVATIVES OF GITOXY INDIGITOXOSIDES AND THE PROCESS FOR THEIR PRODUCTION | |
DE1545635A1 (en) | Process for the preparation of adenosine derivatives | |
DE1071699B (en) | Process for the preparation of 21-acylloxy-16,17-oxiido-3-ketosteroidJen | |
DE1593351A1 (en) | Process for the preparation of gestagenic compounds | |
DE1667896A1 (en) | Androgen antagonists | |
DE1113453B (en) | Process for the production of substitution products of Reichsteins-Substance-S or their 21-acylates | |
DE1169928B (en) | Process for the preparation of 21-bromo-5ª ‡ - or -5ª ‰ -pregnan-20-ones | |
DE1543467A1 (en) | Process for the production of 6,6-ethylene pregnenes | |
DE1793344A1 (en) | 2-halo-18-methyl-1-androstene | |
DE2008645A1 (en) | Steroid lactones | |
DD157097A1 (en) | PROCESS FOR PREPARING HYDROXY-ANDROSTAN-3,17-DIONES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHN | Withdrawal |